Gainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
U.S. stocks closed lower with the Nasdaq Composite dropping more than 300 points on Thursday. Here is the list of some big stocks recording losses in the previous session.
Donald Trump received a legal boost on Thursday after Florida federal judge Aileen Cannon issued an order extending the time for the review of materials seized from the former president’s Mar-a-Lago estate.
On Wednesday, Immunovant Inc (NASDAQ:IMVT) announced a new anti-FcRn, IMVT-1402, at Roivant Sciences Ltd’s (NASDAQ:ROIV) Investor Day. IMVT-1402 is a new anti-FcRn monoclonal antibody…